Hypofractionated radiotherapy shows comparable oncological outcomes in localized prostate cancer, indicating its safety and efficacy.
Hypofractionated radiotherapy demonstrated comparable oncological outcomes and an acceptable toxicity profile to those of conventionally fractionated radiotherapy in patients with low- to intermediate-risk prostate cancer.
No takes yet. Share an insight, caveat, or question.
Iida et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: